What is JAMES HARDIE INDUS CDI's earnings per share (EPS)?

JAMES HARDIE INDUS CDI (JHIUF) reported diluted earnings per share of $0.19 for fiscal year 2026. This represents a -80.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

JAMES HARDIE INDUS CDI (JHIUF) Financials

JHIUF

FY2026 annual

Revenue $4.8B +24.7% YoY

Net Income $104.0M -75.5% YoY

EPS (Diluted) $0.19 -80.6% YoY

Free Cash Flow $205.9M -45.9% YoY

Market Cap $16.2B as of Sep 14, 2026

Price / Sales 3.3x on $4.8B revenue, FY2026

Price / Earnings 156x on $104.0M net income, FY2026

Price / Book 2.5x on $6.5B equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the JHIUF SEC filings page.

JAMES HARDIE INDUS CDI (JHIUF) reported $4.8B in revenue for fiscal year 2026, up 24.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JHIUF FY2026 2026-08-29

A scale jump brought acquisition-heavy assets and financing, while operating costs and interest compressed earnings faster than revenue expanded

FY2026 paired a 24.7% revenue increase with operating-margin compression from 16.9% to 9.3% and net-margin compression to 2.2%, indicating that added volume did not translate proportionally into profit. Operating cash flow of $590M remained well above net income of $104M, largely alongside $494M of depreciation and amortization, but free cash flow fell to $206M after $384M of capital spending.

The FY2026 balance sheet changed shape: assets reached $13.7B, including $4.8B of goodwill, while long-term debt rose to $4.5B and the debt-to-equity ratio reached 0.7x from 0.5x in FY2025. That combination is consistent with a large acquisition or other structural expansion rather than ordinary internal growth.

Funding also appears to have been part of the expansion mechanic: financing provided $3.4B in FY2026 while shares outstanding increased to 580M from 430M. Despite the larger asset base, the current ratio eased to 1.6x from 2.1x, showing that short-term balance-sheet flexibility narrowed as the company scaled.

Financial Health Signals

Financial health score not available

JAMES HARDIE INDUS CDI does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Grey Zone

2.04

JAMES HARDIE INDUS CDI scores 2.04, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($16.2B) relative to total liabilities ($7.3B). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

3/9

JAMES HARDIE INDUS CDI passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed

5.67x

For every $1 of reported earnings, JAMES HARDIE INDUS CDI generates $5.67 in operating cash flow ($589.8M OCF vs $104.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

1.94x

JAMES HARDIE INDUS CDI earns $1.94 in operating income for every $1 of interest expense ($447.6M vs $231.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.5B

YoY+63.9%

JAMES HARDIE INDUS CDI generated $1.5B in revenue in Q1 2027. This represents an increase of 63.9% from the same quarter a year earlier.

EBITDA

$386.5M

YoY+98.1%

JAMES HARDIE INDUS CDI's EBITDA was $386.5M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 98.1% from the same quarter a year earlier.

Net Income

$104.3M

YoY+66.6%

JAMES HARDIE INDUS CDI reported $104.3M in net income in Q1 2027. This represents an increase of 66.6% from the same quarter a year earlier.

EPS (Diluted)

$0.18

YoY+20.0%

JAMES HARDIE INDUS CDI earned $0.18 per diluted share (EPS) in Q1 2027. This represents an increase of 20.0% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow

$254.2M

YoY+145.1%

JAMES HARDIE INDUS CDI generated $254.2M in free cash flow in Q1 2027, representing cash available after capex. This represents an increase of 145.1% from the same quarter a year earlier.

Cash & Debt

$289.9M

YoY-86.3%

QoQ+7.7%

JAMES HARDIE INDUS CDI held $289.9M in cash against $4.2B in long-term debt as of Q1 2027.

Shares Outstanding

581M

QoQ0.0%

JAMES HARDIE INDUS CDI had 581M shares outstanding in Q1 2027. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin

37.2%

YoY-0.2pp

JAMES HARDIE INDUS CDI's gross margin was 37.2% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is down 0.2 percentage points from the same quarter a year earlier.

Operating Margin

14.8%

YoY-0.6pp

JAMES HARDIE INDUS CDI's operating margin was 14.8% in Q1 2027, reflecting core business profitability. This is down 0.6 percentage points from the same quarter a year earlier.

Net Margin

7.1%

YoY+0.1pp

JAMES HARDIE INDUS CDI's net profit margin was 7.1% in Q1 2027, showing the share of revenue converted to profit. This is up 0.1 percentage points from the same quarter a year earlier.

Return on Equity

1.6%

YoY-1.2pp

JAMES HARDIE INDUS CDI's ROE was 1.6% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 1.2 percentage points from the same quarter a year earlier.

Capital Allocation

R&D Spending

$15.4M

YoY+27.3%

JAMES HARDIE INDUS CDI invested $15.4M in research and development in Q1 2027. This represents an increase of 27.3% from the same quarter a year earlier.

Capital Expenditures

$89.8M

YoY-13.0%

JAMES HARDIE INDUS CDI invested $89.8M in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 13.0% from the same quarter a year earlier.

Share Buybacks

Not reported for Q1 2027.

JHIUF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JHIUF quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$4.8B+24.7%	$3.9B-1.5%	$3.9B+4.2%	$3.8B+4.5%	$3.6B+24.3%	$2.9B+11.6%	$2.6B+4.0%	$2.5B+22.0%	$2.1B+6.9%	$1.9B+11.2%	$1.7B+4.3%	$1.7B+10.9%	$1.5B+13.1%	$1.3B+6.8%	$1.2B
Cost of Revenue	$3.1B+30.9%	$2.4B+1.0%	$2.3B-4.8%	$2.5B+7.1%	$2.3B+23.9%	$1.9B+11.0%	$1.7B-0.1%	$1.7B+26.5%	$1.3B+6.2%	$1.2B+13.8%	$1.1B+1.7%	$1.1B+9.2%	$987.4M+9.5%	$902.0M+8.6%	$830.5M
Gross Profit	$1.7B+14.9%	$1.5B-5.3%	$1.6B+21.1%	$1.3B-0.1%	$1.3B+24.9%	$1.1B+12.6%	$933.7M+12.4%	$831.0M+13.8%	$730.2M+8.2%	$674.7M+6.7%	$632.2M+9.2%	$578.8M+14.3%	$506.4M+20.8%	$419.3M+3.0%	$407.0M
R&D Expenses	$60.7M+25.2%	$48.5M+3.2%	$47.0M+18.7%	$39.6M+4.2%	$38.0M+10.8%	$34.3M+4.6%	$32.8M-13.5%	$37.9M+13.8%	$33.3M+9.9%	$30.3M+2.7%	$29.5M-6.9%	$31.7M-4.2%	$33.1M-11.0%	$37.2M+22.4%	$30.4M
SG&A Expenses	$946.4M+58.7%	$596.2M-1.0%	$602.2M+21.9%	$494.0M+7.1%	$461.2M+18.4%	$389.6M-6.3%	$415.8M+3.0%	$403.6M+29.6%	$311.3M+6.8%	$291.6M+14.7%	$254.2M+3.5%	$245.5M+9.4%	$224.4M+2.7%	$218.6M+14.5%	$191.0M
Operating Income	$447.6M-31.8%	$655.9M-14.5%	$767.4M+3.5%	$741.4M+8.6%	$682.6M+44.4%	$472.8M+38.0%	$342.5M-2.6%	$351.6M+53.4%	$229.2M-41.7%	$393.2M+11.1%	$354.0M+5.7%	$335.0M+530.9%	$53.1M+80.0%	$29.5M-81.0%	$155.5M
EBITDA	$941.1M+7.9%	$872.1M-8.4%	$952.4M+4.2%	$914.0M+8.2%	$844.4M+38.9%	$607.8M+28.2%	$474.0M+0.6%	$471.0M+46.6%	$321.2M-32.6%	$476.4M+9.8%	$433.8M+6.9%	$405.9M+254.5%	$114.5M+26.2%	$90.7M-58.9%	$220.7M
Interest Expense	$231.1M+2143.7%	$10.3M-32.7%	$15.3M-50.2%	$30.7M-21.9%	$39.3M	N/A	$57.5M+6.1%	$54.2M+64.7%	$32.9M+15.4%	$28.5M+7.1%	$26.6M+171.4%	$9.8M+117.8%	$4.5M-18.2%	$5.5M-50.9%	$11.2M
Income Tax	$102.7M-53.6%	$221.4M-9.5%	$244.6M+15.7%	$211.5M+14.9%	$184.0M+23.3%	$149.2M+220.9%	$46.5M-35.2%	$71.8M+154.6%	$28.2M-68.8%	$90.5M+5.1%	$86.1M+175.1%	$31.3M+169.7%	-$44.9M-280.5%	-$11.8M+97.4%	-$453.2M
Net Income	$104.0M-75.5%	$424.0M-16.9%	$510.2M-0.4%	$512.0M+11.5%	$459.1M+74.7%	$262.8M+8.8%	$241.5M+5.6%	$228.8M+56.6%	$146.1M-47.2%	$276.5M+13.1%	$244.4M-16.1%	$291.3M+192.8%	$99.5M+118.7%	$45.5M-92.5%	$604.3M
EPS (Basic)	$0.19-80.6%	$0.98-15.5%	$1.16+0.9%	$1.15+11.7%	$1.03+74.6%	$0.59+7.3%	$0.55+5.8%	$0.52+57.6%	$0.33-46.8%	$0.62+12.7%	$0.55-15.4%	$0.65+195.5%	$0.22+120.0%	$0.10-92.8%	$1.39
EPS (Diluted)	$0.19-80.6%	$0.98-15.5%	$1.16+0.9%	$1.15+11.7%	$1.03+74.6%	$0.59+9.3%	$0.54+3.8%	$0.52+57.6%	$0.33-46.8%	$0.62+12.7%	$0.55-15.4%	$0.65+195.5%	$0.22+120.0%	$0.10-92.8%	$1.38
Diluted Shares (Avg)	546M+26.2%	432M-1.7%	440M-1.3%	446M-0.1%	446M+0.1%	445M+0.3%	444M+0.2%	443M+0.2%	442M-0.4%	444M-0.7%	447M+0.2%	446M+0.4%	445M+0.9%	441M+0.6%	438M

Metric	Q1'2710-Q	Q4'2610-Q	Q1'2610-Q	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K
Revenue	$1.5B+63.9%	N/A	$899.9M	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	$925.9M+64.5%	N/A	$563.0M	N/A	N/A	N/A	N/A	N/A
Gross Profit	$548.7M+62.9%	N/A	$336.9M	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$15.4M+27.3%	N/A	$12.1M	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$295.4M+89.2%	N/A	$156.1M	N/A	N/A	N/A	N/A	N/A
Operating Income	$217.7M+57.1%	N/A	$138.6M	N/A	N/A	N/A	N/A	N/A
EBITDA	$386.5M+98.1%	N/A	$195.1M	N/A	N/A	N/A	N/A	N/A
Interest Expense	$61.5M+62.7%	N/A	$37.8M	N/A	N/A	N/A	N/A	N/A
Income Tax	$53.0M+95.6%	N/A	$27.1M	N/A	N/A	N/A	N/A	N/A
Net Income	$104.3M+66.6%	N/A	$62.6M	N/A	N/A	N/A	N/A	N/A
EPS (Basic)	$0.18+20.0%	N/A	$0.15	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	$0.18+20.0%	N/A	$0.15	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	584M+35.5%	N/A	431M	N/A	N/A	N/A	N/A	N/A

JHIUF Balance Sheet

JHIUF quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$13.7B+161.7%	$5.2B+6.5%	$4.9B+9.7%	$4.5B+5.6%	$4.2B+3.8%	$4.1B+1.5%	$4.0B-0.1%	$4.0B+71.5%	$2.4B+16.8%	$2.0B-0.8%	$2.0B-0.7%	$2.0B-2.8%	$2.1B-0.4%	$2.1B-8.5%	$2.3B
Current Assets	$1.8B+7.3%	$1.7B+19.1%	$1.4B+32.9%	$1.1B-4.4%	$1.1B+19.1%	$943.6M+3.9%	$908.4M+20.5%	$754.1M-10.5%	$842.6M+33.3%	$632.1M+18.3%	$534.3M+2.0%	$524.0M-20.5%	$659.1M-5.4%	$696.6M-19.6%	$866.4M
Cash & Equivalents	$269.2M-52.2%	$562.7M+54.2%	$365.0M+223.0%	$113.0M-9.6%	$125.0M-40.0%	$208.5M+44.4%	$144.4M+83.5%	$78.7M-72.1%	$281.6M+256.9%	$78.9M-26.3%	$107.1M+59.9%	$67.0M-60.0%	$167.5M+9.0%	$153.7M-42.1%	$265.4M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$635.7M+83.1%	$347.1M+2.8%	$337.8M-1.9%	$344.2M+23.1%	$279.7M+28.1%	$218.3M-28.4%	$305.1M-3.9%	$317.4M+24.1%	$255.7M+26.0%	$202.9M+5.1%	$193.0M-11.5%	$218.0M+16.9%	$186.5M+8.4%	$172.1M-4.3%	$179.8M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.8B+2367.9%	$193.7M+0.6%	$192.6M-1.2%	$194.9M-2.3%	$199.5M-4.7%	$209.3M+6.3%	$196.9M-2.1%	$201.1M+4004.1%	$4.9M	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$7.3B+136.7%	$3.1B+0.5%	$3.1B+6.5%	$2.9B-1.5%	$2.9B-3.9%	$3.0B+1.2%	$3.0B-2.1%	$3.1B+18.9%	$2.6B+15.6%	$2.2B-1.3%	$2.3B+0.3%	$2.2B-2.4%	$2.3B+9.9%	$2.1B-4.1%	$2.2B
Current Liabilities	$1.2B+42.9%	$810.2M+1.6%	$797.7M+14.4%	$697.3M-9.4%	$769.9M-14.6%	$901.1M+76.7%	$510.0M+5.6%	$483.0M+22.4%	$394.6M-8.0%	$428.8M+7.3%	$399.8M+5.8%	$377.9M-30.2%	$541.3M+67.6%	$322.9M-19.9%	$403.1M
Non-Current Liabilities	$6.1B+170.4%	$2.3B+0.1%	$2.3B+3.9%	$2.2B+1.4%	$2.1B+0.6%	$2.1B-14.3%	$2.5B-3.6%	$2.6B+18.2%	$2.2B+21.3%	$1.8B-3.2%	$1.9B-0.8%	$1.9B+6.1%	$1.8B-0.6%	$1.8B-0.5%	$1.8B
Long-Term Debt	$4.5B+304.6%	$1.1B-0.4%	$1.1B+5.3%	$1.1B+20.7%	$877.3M+2.2%	$858.6M-36.6%	$1.4B-1.9%	$1.4B+56.1%	$884.4M+56.7%	$564.5M+12.5%	$501.8M+26.2%	$397.5M	N/A	N/A	N/A
Total Equity	$6.4B+197.3%	$2.2B+16.3%	$1.9B+15.4%	$1.6B+20.9%	$1.3B+25.7%	$1.1B+2.5%	$1.0B+6.3%	$974.4M+539.9%	-$221.5M-4.4%	-$212.2M+5.8%	-$225.2M-11.2%	-$202.6M-1.8%	-$199.0M-1193.4%	$18.2M-85.6%	$126.4M
Retained Earnings	$1.8B+6.0%	$1.7B+19.3%	$1.4B+20.8%	$1.2B+34.1%	$892.4M+46.0%	$611.4M-7.3%	$659.5M+14.3%	$577.1M+190.8%	-$635.3M-3.7%	-$612.9M+1.4%	-$621.8M-6.0%	-$586.6M+2.6%	-$602.4M-68.5%	-$357.6M-66.6%	-$214.6M

Metric	Q1'2710-Q	Q4'2610-Q	Q1'2610-Q	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K
Total Assets	$13.5B	$13.7B+161.7%	N/A	$5.2B+6.5%	$4.9B+9.7%	$4.5B+5.6%	$4.2B+3.8%	$4.1B+1.5%
Current Assets	$1.8B	$1.8B+7.3%	N/A	$1.7B+19.1%	$1.4B+32.9%	$1.1B-4.4%	$1.1B+19.1%	$943.6M+3.9%
Cash & Equivalents	$289.9M-86.3%	$269.2M-52.2%	$2.1B	$562.7M+54.2%	$365.0M+223.0%	$113.0M-9.6%	$125.0M-40.0%	$208.5M+44.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$612.1M	$635.7M+83.1%	N/A	$347.1M+2.8%	$337.8M-1.9%	$344.2M+23.1%	$279.7M+28.1%	$218.3M-28.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.8B	$4.8B+2367.9%	N/A	$193.7M+0.6%	$192.6M-1.2%	$194.9M-2.3%	$199.5M-4.7%	$209.3M+6.3%
Total Liabilities	$7.0B	$7.3B+136.7%	N/A	$3.1B+0.5%	$3.1B+6.5%	$2.9B-1.5%	$2.9B-3.9%	$3.0B+1.2%
Current Liabilities	$1.1B	$1.2B+42.9%	N/A	$810.2M+1.6%	$797.7M+14.4%	$697.3M-9.4%	$769.9M-14.6%	$901.1M+76.7%
Non-Current Liabilities	$5.8B	$6.1B+170.4%	N/A	$2.3B+0.1%	$2.3B+3.9%	$2.2B+1.4%	$2.1B+0.6%	$2.1B-14.3%
Long-Term Debt	$4.2B	$4.5B+304.6%	N/A	$1.1B-0.4%	$1.1B+5.3%	$1.1B+20.7%	$877.3M+2.2%	$858.6M-36.6%
Total Equity	$6.5B+189.9%	$6.4B+197.3%	$2.3B	$2.2B+16.3%	$1.9B+15.4%	$1.6B+20.9%	$1.3B+25.7%	$1.1B+2.5%
Retained Earnings	$1.9B	$1.8B+6.0%	N/A	$1.7B+19.3%	$1.4B+20.8%	$1.2B+34.1%	$892.4M+46.0%	$611.4M-7.3%

Not reported in any period shown, so not listed: Accounts Receivable.

JHIUF Cash Flow Statement

JHIUF quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$589.8M-26.5%	$802.8M-12.2%	$914.2M+50.5%	$607.6M-19.8%	$757.2M-3.8%	$786.9M+74.4%	$451.2M+48.4%	$304.0M-1.5%	$308.5M-19.3%	$382.5M+46.9%	$260.4M+45.1%	$179.5M-44.4%	$322.8M+195.3%	$109.3M-71.8%	$387.2M
Depreciation & Amortization	$493.5M+128.3%	$216.2M+16.9%	$185.0M+7.2%	$172.6M+6.7%	$161.8M+19.9%	$135.0M+2.7%	$131.5M+10.1%	$119.4M+29.8%	$92.0M+10.6%	$83.2M+4.3%	$79.8M+12.6%	$70.9M+15.5%	$61.4M+0.3%	$61.2M-6.1%	$65.2M
Stock-Based Compensation	$38.0M+65.2%	$23.0M-18.4%	$28.2M+79.6%	$15.7M+74.4%	$9.0M-50.0%	$18.0M+74.8%	$10.3M-17.6%	$12.5M+12.6%	$11.1M+19.4%	$9.3M-9.7%	$10.3M+12.0%	$9.2M+8.2%	$8.5M+21.4%	$7.0M-10.3%	$7.8M
Capital Expenditures	$383.9M-9.1%	$422.2M-6.0%	$449.3M-24.0%	$591.3M+129.4%	$257.8M+132.9%	$110.7M-42.9%	$193.8M-39.0%	$317.5M+51.0%	$210.2M+106.3%	$101.9M+39.2%	$73.2M-73.5%	$276.2M+139.3%	$115.4M+88.9%	$61.1M+70.7%	$35.8M
Free Cash Flow	$205.9M-45.9%	$380.6M-18.1%	$464.9M+2752.1%	$16.3M-96.7%	$499.4M-26.1%	$676.2M+162.7%	$257.4M+2006.7%	-$13.5M-113.7%	$98.3M-65.0%	$280.6M+49.9%	$187.2M+293.6%	-$96.7M-146.6%	$207.4M+330.3%	$48.2M-86.3%	$351.4M
Investing Cash Flow	-$4.2B-842.1%	-$446.7M+5.1%	-$470.5M+28.7%	-$660.1M-89.6%	-$348.2M-189.2%	-$120.4M+40.9%	-$203.8M+76.4%	-$864.4M-252.1%	-$245.5M	N/A	N/A	N/A	-$118.8M-99.0%	-$59.7M-19.6%	-$49.9M
Financing Cash Flow	$3.4B+2119.8%	-$165.9M+21.0%	-$210.1M-727.2%	-$25.4M+94.4%	-$449.6M+16.8%	-$540.2M-201.8%	-$179.0M-149.1%	$364.2M+501.0%	$60.6M	N/A	N/A	N/A	-$186.3M-17.4%	-$158.7M-88.0%	-$84.4M
Dividends Paid	N/A	$0	$0-100.0%	$129.6M-73.2%	$484.0M	$0-100.0%	$158.6M-7.8%	$172.1M-3.0%	$177.5M+0.4%	$176.8M-28.3%	$246.5M-36.8%	$390.1M+95.9%	$199.1M+5.6%	$188.5M+983.3%	$17.4M
Share Buybacks	$0-100.0%	$149.9M-44.8%	$271.4M+246.2%	$78.4M	$0	$0	N/A	$0	$0-100.0%	$99.8M+347.5%	$22.3M+145.1%	$9.1M-58.8%	$22.1M	N/A	$19.0M

Metric	Q1'2710-Q	Q4'2610-Q	Q1'2610-Q	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K
Operating Cash Flow	$344.0M+66.3%	N/A	$206.9M	N/A	N/A	N/A	N/A	N/A
Depreciation & Amortization	$168.8M+198.8%	N/A	$56.5M	N/A	N/A	N/A	N/A	N/A
Stock-Based Compensation	$12.0M+73.9%	N/A	$6.9M	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	$89.8M-13.0%	N/A	$103.2M	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	$254.2M+145.1%	N/A	$103.7M	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$103.6M+1.6%	N/A	-$105.3M	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$261.4M-118.6%	N/A	$1.4B	N/A	N/A	N/A	N/A	N/A

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

JHIUF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JHIUF quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	35.8%-3.0pp	38.8%-1.5pp	40.4%+5.6pp	34.7%-1.6pp	36.3%+0.2pp	36.2%+0.3pp	35.8%+2.7pp	33.1%-2.4pp	35.5%+0.4pp	35.1%-1.5pp	36.6%+1.7pp	34.9%+1.0pp	33.9%+2.2pp	31.7%-1.2pp	32.9%
Operating Margin	9.3%-7.7pp	16.9%-2.6pp	19.5%-0.1pp	19.6%+0.8pp	18.9%+2.6pp	16.3%+3.1pp	13.1%-0.9pp	14.0%+2.9pp	11.2%-9.3pp	20.5%0.0pp	20.5%+0.3pp	20.2%+16.7pp	3.5%+1.3pp	2.2%-10.3pp	12.6%
Net Margin	2.1%-8.8pp	10.9%-2.0pp	13.0%-0.6pp	13.6%+0.9pp	12.7%+3.7pp	9.0%-0.2pp	9.3%+0.1pp	9.1%+2.0pp	7.1%-7.3pp	14.4%+0.3pp	14.1%-3.4pp	17.6%+10.9pp	6.7%+3.2pp	3.4%-45.4pp	48.8%
Return on Equity	1.6%-18.0pp	19.6%-7.8pp	27.5%-4.3pp	31.8%-2.7pp	34.4%+9.7pp	24.8%+1.4pp	23.3%-0.2pp	23.5%	N/A	N/A	N/A	N/A	N/A	250.0%-228.1pp	478.1%
Return on Assets	0.8%-7.4pp	8.1%-2.3pp	10.4%-1.0pp	11.4%+0.6pp	10.8%+4.4pp	6.4%+0.4pp	6.0%+0.3pp	5.7%-0.5pp	6.2%-7.5pp	13.7%+1.7pp	12.0%-2.2pp	14.2%+9.5pp	4.7%+2.6pp	2.1%-24.0pp	26.2%
Current Ratio	1.58-0.5x	2.10+0.3x	1.79+0.2x	1.54+0.1x	1.46+0.4x	1.05-0.7x	1.78+0.2x	1.56-0.6x	2.14+0.7x	1.47+0.1x	1.34-0.1x	1.39+0.2x	1.22-0.9x	2.160.0x	2.15
Debt-to-Equity	0.70+0.2x	0.51-0.1x	0.60-0.1x	0.660.0x	0.66-0.2x	0.81-0.5x	1.31-0.1x	1.42	N/A	N/A	N/A	N/A	N/A	115.11+97.8x	17.28
Asset Turnover	0.35-0.4x	0.74-0.1x	0.800.0x	0.840.0x	0.85+0.1x	0.71+0.1x	0.650.0x	0.62-0.3x	0.87-0.1x	0.95+0.1x	0.850.0x	0.81+0.1x	0.71+0.1x	0.63+0.1x	0.54
FCF Margin	4.3%-5.6pp	9.8%-2.0pp	11.8%+11.4pp	0.4%-13.4pp	13.8%-9.4pp	23.3%+13.4pp	9.9%+10.4pp	-0.5%-5.3pp	4.8%-9.8pp	14.6%+3.8pp	10.8%+16.7pp	-5.8%-19.7pp	13.9%+10.2pp	3.6%-24.7pp	28.4%

Metric	Q1'2710-Q	Q4'2610-Q	Q1'2610-Q	Q4'2510-K	Q4'2410-K	Q4'2310-K	Q4'2210-K	Q4'2110-K
Gross Margin	37.2%-0.2pp	N/A	37.4%	N/A	N/A	N/A	N/A	N/A
Operating Margin	14.8%-0.6pp	N/A	15.4%	N/A	N/A	N/A	N/A	N/A
Net Margin	7.1%+0.1pp	N/A	7.0%	N/A	N/A	N/A	N/A	N/A
Return on Equity	1.6%-1.2pp	N/A	2.8%	N/A	N/A	N/A	N/A	N/A
Return on Assets	0.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.59	1.58-0.5x	N/A	2.10+0.3x	1.79+0.2x	1.54+0.1x	1.46+0.4x	1.05-0.7x
Debt-to-Equity	0.65	0.70+0.2x	N/A	0.51-0.1x	0.60-0.1x	0.660.0x	0.66-0.2x	0.81-0.5x
Asset Turnover	0.11	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	17.2%+5.7pp	N/A	11.5%	N/A	N/A	N/A	N/A	N/A

Where JAMES HARDIE INDUS CDI Ranks

Frequently Asked Questions

What is JAMES HARDIE INDUS CDI's annual revenue?

JAMES HARDIE INDUS CDI (JHIUF) reported $4.8B in total revenue for fiscal year 2026. This represents a 24.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is JAMES HARDIE INDUS CDI's revenue growing?

JAMES HARDIE INDUS CDI (JHIUF) revenue grew by 24.7% year-over-year, from $3.9B to $4.8B in fiscal year 2026.

Is JAMES HARDIE INDUS CDI profitable?

Yes, JAMES HARDIE INDUS CDI (JHIUF) reported a net income of $104.0M in fiscal year 2026, with a net profit margin of 2.1%.

What is JAMES HARDIE INDUS CDI's EBITDA?

JAMES HARDIE INDUS CDI (JHIUF) had EBITDA of $941.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does JAMES HARDIE INDUS CDI have?

As of fiscal year 2026, JAMES HARDIE INDUS CDI (JHIUF) had $269.2M in cash and equivalents against $4.5B in long-term debt.

What is JAMES HARDIE INDUS CDI's gross margin?

JAMES HARDIE INDUS CDI (JHIUF) had a gross margin of 35.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is JAMES HARDIE INDUS CDI's operating margin?

JAMES HARDIE INDUS CDI (JHIUF) had an operating margin of 9.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is JAMES HARDIE INDUS CDI's net profit margin?

JAMES HARDIE INDUS CDI (JHIUF) had a net profit margin of 2.1% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is JAMES HARDIE INDUS CDI's return on equity (ROE)?

JAMES HARDIE INDUS CDI (JHIUF) has a return on equity of 1.6% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is JAMES HARDIE INDUS CDI's free cash flow?

JAMES HARDIE INDUS CDI (JHIUF) generated $205.9M in free cash flow during fiscal year 2026. This represents a -45.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is JAMES HARDIE INDUS CDI's operating cash flow?

JAMES HARDIE INDUS CDI (JHIUF) generated $589.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are JAMES HARDIE INDUS CDI's total assets?

JAMES HARDIE INDUS CDI (JHIUF) had $13.7B in total assets as of fiscal year 2026, including both current and long-term assets.

What are JAMES HARDIE INDUS CDI's capital expenditures?

JAMES HARDIE INDUS CDI (JHIUF) invested $383.9M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does JAMES HARDIE INDUS CDI spend on research and development?

JAMES HARDIE INDUS CDI (JHIUF) invested $60.7M in research and development during fiscal year 2026.

How many shares does JAMES HARDIE INDUS CDI have outstanding?

JAMES HARDIE INDUS CDI (JHIUF) had 580M shares outstanding as of fiscal year 2026.

What is JAMES HARDIE INDUS CDI's current ratio?

JAMES HARDIE INDUS CDI (JHIUF) had a current ratio of 1.58 as of fiscal year 2026, which is generally considered healthy.

What is JAMES HARDIE INDUS CDI's debt-to-equity ratio?

JAMES HARDIE INDUS CDI (JHIUF) had a debt-to-equity ratio of 0.70 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is JAMES HARDIE INDUS CDI's return on assets (ROA)?

JAMES HARDIE INDUS CDI (JHIUF) had a return on assets of 0.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is JAMES HARDIE INDUS CDI's P/E ratio?

JAMES HARDIE INDUS CDI (JHIUF) trades at 156x earnings, its market capitalization divided by net income of $104.0M net income, FY2026. The market capitalization is $16.2B as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is JAMES HARDIE INDUS CDI's price-to-sales ratio?

JAMES HARDIE INDUS CDI (JHIUF) trades at 3.3x sales, its market capitalization divided by revenue of $4.8B revenue, FY2026. The market capitalization is $16.2B as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is JAMES HARDIE INDUS CDI's Altman Z-Score?

JAMES HARDIE INDUS CDI (JHIUF) has an Altman Z-Score of 2.04, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is JAMES HARDIE INDUS CDI's Piotroski F-Score?

JAMES HARDIE INDUS CDI (JHIUF) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are JAMES HARDIE INDUS CDI's earnings high quality?

JAMES HARDIE INDUS CDI (JHIUF) has an earnings quality ratio of 5.67x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can JAMES HARDIE INDUS CDI cover its interest payments?

JAMES HARDIE INDUS CDI (JHIUF) has an interest coverage ratio of 1.94x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.